Aehr Test Systems (AEHR)
AEHR vs. COHU: Which Semiconductor Equipment Stock Is The Better Buy?
Aehr's record backlog, AI-driven orders and strong fiscal 2027 outlook give it an edge over Cohu despite a higher valuation.
Can AEHR Turn Silicon Photonics Momentum Into Sustained Growth?
Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.
4 Leveraged ETFs of Last Week
Cooling inflation and softer jobs data have eased Fed rate-hike fears, fueling a strong rally in select growth and AI stocks.
Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026's most explosive small caps.
Can Aehr's $22M AI Order Unlock a Bigger WLBI Opportunity?
AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.
Aehr Test Systems Stock Soars 72% in a Month: Is it Still a Buy?
AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.
The Biggest Market Movers: Aehr Test Systems Climbs on Strong Earnings
Shares of Aehr Test Systems (NASDAQ:AEHR) are up 6.1% in midday trading Tuesday, extending a torrid summer run in the semiconductor test equipment name.
Aehr Test Systems vs. C3.ai: Which Technology Stock Is a Better Buy in 2026?
Aehr Test Systems provides essential wafer-level testing for high-growth sectors like silicon carbide and silicon photonics. C3.ai is transitioning its enterprise software platform toward a consumption-based pricing model to drive broader adoption.
Why Aehr Test Systems (AEHR) Might be Well Poised for a Surge
Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 49.6% in Aehr Test Systems (AEHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
FORM vs. AEHR: Which Semi Test Equipment Stock is a Better Buy?
Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.
Here's Why Aehr Test Systems (AEHR) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Aehr Test Systems (AEHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
